I agree PhilB1. Aethlon is purposely not updating their website. I believe there will be a lot of changes in the near future.
For the past few years or so we have seen:
ELLSA™ Exosome Assay
"As our focus is directed towards advancing the pipeline of Aethlon ADAPT™ system therapies, we plan to license or sell this technology to an organization already established in the research diagnostics field."
No one jumped on ELLSA then, so why now?
Now recently, there has been a huge direction change with the formal introduction of Exosome Sciences Inc. (Including a new home in Langhorne, Pennsylvania)and two "best-known researchers in the exosome field" now hired by Aethlon.
IMO two "best-known researchers" don't jump over to Aethlon unless they see something big in the works. I also think JJ is slowly leading up to bigger news. We haven't heard much of Exosome Sciences lately and just maybe they have been really busy and have other developments in the works. I don't think it's just ELLSA that caused to major players to make such a big move. again IMO.
Market Data 
Markets 
AI
